Estrone
From DrugPedia: A Wikipedia for Drug discovery
Line 18: | Line 18: | ||
'''Mechanism of Action:''' Estrogens enter the cells of responsive tissues (e.g., female organs, breasts, hypothalamus, pituitary) where they interact with a protein receptor, estrogen receptors, subsequently increasing the rate of synthesis of DNA, RNA, and some proteins. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. | '''Mechanism of Action:''' Estrogens enter the cells of responsive tissues (e.g., female organs, breasts, hypothalamus, pituitary) where they interact with a protein receptor, estrogen receptors, subsequently increasing the rate of synthesis of DNA, RNA, and some proteins. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. | ||
Indication: For management of Menopausal and postmenopausal disorders | Indication: For management of Menopausal and postmenopausal disorders | ||
- | Half Life: 19 hours | + | |
+ | '''Half Life:''' 19 hours | ||
Lipinski’s “Rule of Five” Prediction for a Compound’s ABSORPTION OR PERMEABILITY PROPERTIES | Lipinski’s “Rule of Five” Prediction for a Compound’s ABSORPTION OR PERMEABILITY PROPERTIES | ||
Line 26: | Line 27: | ||
1 INDETERMINATE | 1 INDETERMINATE | ||
0 POOR | 0 POOR | ||
- | + | {| border="1;width:100%; height:200px;style=text-align:center" | |
- | + | |+'''Table I:''' | |
- | + | |- | |
- | Physical Property | + | ! style="background:brown; color:white" |Physical Property |
- | Melting Point 260.2 deg C | + | ! style="background:brown; color:white" |Value |
- | Boiling Point 154 deg C | + | ! style="background:brown; color:white" |Units |
- | log P (octanol-water) 3.13 (none) | + | ! style="background:brown; color:white" |Temp (deg C) |
- | Water Solubility 30 mg/L 25 EXP | + | ! style="background:brown; color:white" |Source |
- | Vapor Pressure 1.42E-07 mm Hg 25 EST | + | |- |
- | Henry's Law Constant 3.80E-10 atm-m3/mole 25 EST | + | |Melting Point |
- | Atmospheric OH Rate Constant 1.26E-10 cm3/molecule-sec 25 EST | + | |260.2 |
+ | |deg C | ||
+ | | | ||
+ | |EXP | ||
+ | |- | ||
+ | |Boiling Point | ||
+ | |154 | ||
+ | |deg C | ||
+ | | | ||
+ | |EXP | ||
+ | |- | ||
+ | |log P (octanol-water) | ||
+ | |3.13 | ||
+ | |(none) | ||
+ | | | ||
+ | |EXP | ||
+ | |- | ||
+ | |Water Solubility | ||
+ | |30 | ||
+ | |mg/L | ||
+ | |25 | ||
+ | |EXP | ||
+ | |- | ||
+ | |Vapor Pressure | ||
+ | |1.42E-07 | ||
+ | |mm Hg | ||
+ | |25 | ||
+ | |EST | ||
+ | |- | ||
+ | |Henry's Law Constant | ||
+ | |3.80E-10 | ||
+ | |atm-m3/mole | ||
+ | |25 | ||
+ | |EST | ||
+ | |- | ||
+ | |Atmospheric OH Rate Constant | ||
+ | |1.26E-10 | ||
+ | |cm3/molecule-sec | ||
+ | |25 | ||
+ | |EST | ||
+ | |- | ||
+ | |} |
Revision as of 08:37, 24 October 2008
Estrone(oestrone)
Pubchem(5870)
An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
KEGG Pathway(C00468,D00067)
- Androgen and estrogen metabolism
Activity Estrogen
NEXTBIO
Drug Type: Small Molecule; Approved
Pharmacology: Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.
Mechanism of Action: Estrogens enter the cells of responsive tissues (e.g., female organs, breasts, hypothalamus, pituitary) where they interact with a protein receptor, estrogen receptors, subsequently increasing the rate of synthesis of DNA, RNA, and some proteins. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. Indication: For management of Menopausal and postmenopausal disorders
Half Life: 19 hours
Lipinski’s “Rule of Five” Prediction for a Compound’s ABSORPTION OR PERMEABILITY PROPERTIES 4 GOOD 3 INDETERMINATE 2 INDETERMINATE 1 INDETERMINATE 0 POOR
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 260.2 | deg C | EXP | |
Boiling Point | 154 | deg C | EXP | |
log P (octanol-water) | 3.13 | (none) | EXP | |
Water Solubility | 30 | mg/L | 25 | EXP |
Vapor Pressure | 1.42E-07 | mm Hg | 25 | EST |
Henry's Law Constant | 3.80E-10 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 1.26E-10 | cm3/molecule-sec | 25 | EST |